New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - tetracosactide 1 mg/ml equivalent to tetracosactide hexaacetate 1.12 mg/ml - injection (depot) - 1 mg/ml - active: tetracosactide 1 mg/ml equivalent to tetracosactide hexaacetate 1.12 mg/ml excipient: benzyl alcohol dibasic sodium phosphate dodecahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection zinc chloride - diagnostic use for the investigation of adrenocortical insufficiency: a 5-hour test canbe peerformed using synacthen depot when the 30-minute test with synacthen i.m./i.v. gives inconclusive results, or if the aim is to determine the functional reserve of the adrenal cortex.

New Zealand - English - Medsafe (Medicines Safety Authority)

clinect nz pty limited - tetracosactide 0.25 mg/ml equivalent to tetracosactide hexaacetate 0.28 mg/ml - solution for injection - 0.25 mg/ml - active: tetracosactide 0.25 mg/ml equivalent to tetracosactide hexaacetate 0.28 mg/ml excipient: acetic acid sodium acetate trihydrate sodium chloride water for injection - for the investigation of adrenocortical insufficiency

Canada - English - Health Canada

atnahs pharma uk limited - tetracosactide (tetracosactide zinc hydroxide) - suspension - 1mg - tetracosactide (tetracosactide zinc hydroxide) 1mg - adrenocortical insufficiency

Ireland - English - HPRA (Health Products Regulatory Authority)

alfasigma s.p.a - tetracosactide acetate - solution for injection - 250 mcg/ml microgram(s)/millilitre - acth; tetracosactide

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alfasigma s.p.a. - tetracosactide acetate - eq. tetracosactide 0,25 mg/ml - solution for injection - 0,25 mg/ml - tetracosactide acetate - tetracosactide

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

alfasigma s.p.a. - tetracosactide acetate - eq. tetracosactide 1 mg/ml - suspension for injection - 1 mg/ml - tetracosactide acetate - tetracosactide

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

dechra regulatory b.v. - tetracosactide hexaacetate 0,28 mg/ml - eq. tetracosactide 0,25 mg/ml - solution for injection - 0,25 mg/ml - tetracosactide hexaacetate 0.28 mg/ml - tetracosactide - dog

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - tetracosactide hexaacetate - solution for injection - 0.25 milligram(s)/millilitre - tetracosactide

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - tetracosactide, quantity: 1 mg/ml - injection, modified release - excipient ingredients: hydrochloric acid; water for injections; dibasic sodium phosphate dihydrate; sodium chloride; zinc chloride; sodium hydroxide; benzyl alcohol - neurological diseases: acute exacerbations in patients suffering from multiple sclerosis. hypsarrhythmia, and or infantile spasms

Australia - English - Department of Health (Therapeutic Goods Administration)

atnahs pharma australia pty ltd - tetracosactide, quantity: 0.25 mg/ml - injection, solution - excipient ingredients: water for injections; sodium chloride; acetic acid; sodium acetate - indications as at 12 august 1999: as a diagnostic aid in the assessment of suspected adrenocortical hypofunction.